OUTCOME OF TREATMENT DISCONTINUATION IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA AND NO EVIDENCE OF DISEASE FOLLOWING TARGETED THERAPY WITH OR WITHOUT METASTASECTOMY ArticleJohannsen M., Miller K., Weikert S., Staehler M., Ohlmann C.H., Flörcken A., Schmittel A., Otto T., Bex A., Hein P., Grünwald V.Annals of Oncology. Том 22. 2011. С. 657-663
THE FUSE BINDING PROTEINS FBP1 AND FBP3 ARE POTENTIAL C-MYC REGULATORS IN RENAL, BUT NOT IN PROSTATE AND BLADDER CANCER ArticleWeber A., Kristiansen I., Behnke S., Moch H., Kristiansen G., Johannsen M., Oelrich B., Meyer H.A., Scholmann K., Gunia S., May M.BMC CANCER. Том 8. 2008. 369 с.
